{"id":"https://openalex.org/W3211177828","doi":"https://doi.org/10.1007/s12325-021-01928-y","title":"Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017\u20132019","display_name":"Epidemiology and Clinical Characteristics of Individuals with Hepatitis C Virus Infection in the United States, 2017\u20132019","publication_year":2021,"publication_date":"2021-10-27","ids":{"openalex":"https://openalex.org/W3211177828","doi":"https://doi.org/10.1007/s12325-021-01928-y","mag":"3211177828","pmid":"https://pubmed.ncbi.nlm.nih.gov/34704194","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8548268"},"language":"en","primary_location":{"id":"doi:10.1007/s12325-021-01928-y","doi":"https://doi.org/10.1007/s12325-021-01928-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-021-01928-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-021-01928-y.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s12325-021-01928-y.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073568589","display_name":"Nancy S. Reau","orcid":"https://orcid.org/0000-0003-2290-4580","observed_orcids":["https://orcid.org/0000-0003-2290-4580"]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Reau","raw_affiliation_strings":["Rush University Medical Center, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rush University Medical Center, Chicago, IL, USA","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054201295","display_name":"Mark Sulkowski","orcid":"https://orcid.org/0000-0002-2145-6352","observed_orcids":["https://orcid.org/0000-0002-2145-6352"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark S. Sulkowski","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022711470","display_name":"Emmanuel Thomas","orcid":"https://orcid.org/0000-0003-1416-3903","observed_orcids":["https://orcid.org/0000-0003-1416-3903"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emmanuel Thomas","raw_affiliation_strings":["University of Miami Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Miami Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067234928","display_name":"Vinay Sundaram","orcid":"https://orcid.org/0000-0002-1450-7756","observed_orcids":["https://orcid.org/0000-0002-1450-7756"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vinay Sundaram","raw_affiliation_strings":["Department of Medicine and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026179583","display_name":"Qingqing Xu","orcid":"https://orcid.org/0000-0002-7703-5872","observed_orcids":["https://orcid.org/0000-0002-7703-5872"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qingqing Xu","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109366387","display_name":"Wei\u2010Han Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei-Han Cheng","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002808124","display_name":"Steven E. Marx","orcid":"https://orcid.org/0000-0002-2171-1923","observed_orcids":["https://orcid.org/0000-0002-2171-1923"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven E. Marx","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111088654","display_name":"Oscar Hayes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oscar A. Hayes","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021012750","display_name":"Shivaji R. Manthena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shivaji R. Manthena","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084341014","display_name":"Viktor Chirikov","orcid":"https://orcid.org/0000-0002-9480-0580","observed_orcids":["https://orcid.org/0000-0002-9480-0580"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Viktor Chirikov","raw_affiliation_strings":["OPEN Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OPEN Health, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046129231","display_name":"Douglas E. Dylla","orcid":"https://orcid.org/0000-0003-1991-127X","observed_orcids":["https://orcid.org/0000-0003-1991-127X"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas E. Dylla","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hannah Brooks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hannah Brooks","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020697020","display_name":"Jana M. Carabino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jana M. Carabino","raw_affiliation_strings":["AbbVie Inc., North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc., North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078234841","display_name":"Sammy Saab","orcid":"https://orcid.org/0000-0003-3346-9297","observed_orcids":["https://orcid.org/0000-0003-3346-9297"]},"institutions":[{"id":"https://openalex.org/I2801272649","display_name":"Ronald Reagan UCLA Medical Center","ror":"https://ror.org/04k3jt835","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801272649"]},{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sammy Saab","raw_affiliation_strings":["UCLA Medical Center, 200 Medical Plaza Driveway, Los Angeles, CA, 90095, USA. SSaab@mednet.ucla.edu","UCLA Medical Center, 200 Medical Plaza Driveway, Los Angeles, CA, 90095, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Medical Center, 200 Medical Plaza Driveway, Los Angeles, CA, 90095, USA. SSaab@mednet.ucla.edu","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]},{"raw_affiliation_string":"UCLA Medical Center, 200 Medical Plaza Driveway, Los Angeles, CA, 90095, USA","institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5078234841"],"corresponding_institution_ids":["https://openalex.org/I2801272649","https://openalex.org/I2801403999"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":1.1745,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.75569103,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"38","issue":"12","first_page":"5777","last_page":"5790"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10276","display_name":"Helicobacter pylori-related gastroenterology studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.8289999961853027},{"id":"https://openalex.org/keywords/hcv-screening","display_name":"HCV screening","score":0.7540000081062317},{"id":"https://openalex.org/keywords/hcv-antibody-testing","display_name":"HCV antibody testing","score":0.7670000195503235},{"id":"https://openalex.org/keywords/hcv-rna-testing","display_name":"HCV RNA testing","score":0.7850000262260437},{"id":"https://openalex.org/keywords/hcv-genotype-3","display_name":"HCV genotype 3","score":0.7070000171661377},{"id":"https://openalex.org/keywords/liver-fibrosis-stage","display_name":"liver fibrosis stage","score":0.8740000128746033},{"id":"https://openalex.org/keywords/hiv-coinfection","display_name":"HIV coinfection","score":0.9620000123977661},{"id":"https://openalex.org/keywords/direct-acting-antivirals","display_name":"direct-acting antivirals","score":0.9309999942779541},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hcv-epidemiology","display_name":"HCV epidemiology","score":0.6359999775886536},{"id":"https://openalex.org/keywords/access-to-treatment","display_name":"access to treatment","score":0.5450000166893005},{"id":"https://openalex.org/keywords/united-states","display_name":"United States","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9220514297485352},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.7649848461151123},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.6147750616073608},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.49156031012535095},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.4912356734275818},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3805698752403259},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.30122315883636475}],"mesh":[{"descriptor_ui":"D000072230","descriptor_name":"Sustained Virologic Response","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s12325-021-01928-y","doi":"https://doi.org/10.1007/s12325-021-01928-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-021-01928-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-021-01928-y.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7437875","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC8548268","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:34704194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34704194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8548268","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8548268/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adv Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s12325-021-01928-y","doi":"https://doi.org/10.1007/s12325-021-01928-y","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s12325-021-01928-y","pdf_url":"https://link.springer.com/content/pdf/10.1007/s12325-021-01928-y.pdf","source":{"id":"https://openalex.org/S27230875","display_name":"Advances in Therapy","issn_l":"0741-238X","issn":["0741-238X","1865-8652"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G4611040392","display_name":null,"funder_award_id":"L30 AI107941","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000881579","display_name":"A Multifaceted Approach to Study Tissue and Cell Type Specific Molecular Mechanisms of the Host Response to Acute/Chronic Viral Infection","funder_award_id":"R35GM124915","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320309117","display_name":"AbbVie","ror":"https://ror.org/02g5p4n58"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3211177828.pdf","grobid_xml":"https://content.openalex.org/works/W3211177828.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1505788137","https://openalex.org/W1868139921","https://openalex.org/W1966188054","https://openalex.org/W2064387090","https://openalex.org/W2301268862","https://openalex.org/W2479225384","https://openalex.org/W2805345171","https://openalex.org/W2806737009","https://openalex.org/W2896231494","https://openalex.org/W2899072245","https://openalex.org/W2906539360","https://openalex.org/W3000353149","https://openalex.org/W3010174353","https://openalex.org/W3015315374","https://openalex.org/W3043954188","https://openalex.org/W3044995086","https://openalex.org/W3046386525","https://openalex.org/W3048332638","https://openalex.org/W3119906745","https://openalex.org/W3165155616","https://openalex.org/W3191920942","https://openalex.org/W4226217676","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W4391747791","https://openalex.org/W4414614031","https://openalex.org/W4200404790","https://openalex.org/W4311817113","https://openalex.org/W2805345171","https://openalex.org/W2053527120","https://openalex.org/W4310896297","https://openalex.org/W2891882231","https://openalex.org/W4283268821","https://openalex.org/W4327605300"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Hepatitis":[1],"C":[2],"virus":[3],"(HCV)":[4],"is":[5],"the":[6,13,24,33,40,51,136,199,220,262],"most":[7],"common":[8],"bloodborne":[9],"chronic":[10],"infection":[11,31],"in":[12,22,32,88,105,149,153,170,174,189,193,233,237],"US.":[14],"Following":[15],"approval":[16],"of":[17,42,56,114,138,157,180,212,242,254,276,281],"highly":[18],"effective,":[19],"direct-acting":[20],"antivirals":[21],"2014,":[23],"diagnostic":[25,48],"and":[26,50,54,61,101,111,129,176,205,273],"treatment":[27,55,110],"rates":[28,229,275],"for":[29,66,71,141,293],"HCV":[30,45,67,72,95,106,109,142,162,181,196,243,257],"US":[34,83],"have":[35],"evolved.":[36],"This":[37],"study":[38],"assessed":[39,104],"number":[41,137,179,253],"individuals":[43,58,139,158,183,213,245,255,283],"with":[44,201,270],"screening":[46],"or":[47],"testing":[49],"clinical":[52],"characteristics":[53],"HCV-infected":[57],"between":[59],"2017":[60,77,133,150,171,190,234,249],"2019.":[62,154,177,194,238,251],"METHODS:":[63],"Individuals":[64],"screened":[65],"antibody":[68,143,163],"and/or":[69],"tested":[70,140,159,256],"ribonucleic":[73],"acid":[74],"(RNA)":[75],"from":[76,147,168,187,231,248],"to":[78,134,151,172,191,224,235,250,296],"2019":[79],"by":[80,145,185],"two":[81],"large":[82],"laboratory":[84],"companies":[85],"were":[86,103,118,161,284],"included":[87],"this":[89,288],"analysis.":[90],"Clinical":[91],"characteristics,":[92],"such":[93],"as":[94],"genotype,":[96],"fibrosis":[97,207,272],"stage,":[98],"HIV":[99],"coinfection":[100],"demographics,":[102],"RNA-positive":[107,182,197],"individuals.":[108],"subsequent":[112],"achievement":[113],"sustained":[115],"virologic":[116],"response":[117],"imputed":[119],"using":[120],"data-driven":[121],"algorithms":[122],"based":[123],"on":[124],"successive":[125],"viral":[126],"load":[127],"decline":[128],"negativity.":[130],"RESULTS:":[131],"From":[132],"2019,":[135],"increased":[144,208,230],"5.7%,":[146],"7,580,303":[148],"8,009,081":[152],"The":[155,178,240,252],"percentage":[156,241],"who":[160],"positive":[164,259],"was":[165],"stable,":[166],"ranging":[167],"5.0%":[169,186],"4.9%":[173],"2018":[175],"decreased":[184,260],"382,500":[188],"363,532":[192],"Of":[195],"individuals,":[198],"proportions":[200,211],"genotype":[202],"(GT)":[203],"3":[204],"minimal":[206],"over":[209,261],"time;":[210],"aged":[214,222],"<":[215],"40":[216],"years":[217,226],"increased,":[218],"while":[219],"proportion":[221],"50":[223],"59":[225],"decreased.":[227],"Treatment":[228],"23.4%":[232],"26.8%":[236],"CONCLUSIONS:":[239],"antibody-positive":[244],"remained":[246],"stable":[247],"RNA":[258],"years.":[263],"Demographics":[264],"shifted":[265],"toward":[266],"a":[267,291],"younger":[268],"population":[269],"less":[271],"higher":[274],"GT3.":[277],"More":[278],"than":[279],"70%":[280],"diagnosed":[282],"not":[285],"treated":[286],"during":[287],"interval,":[289],"highlighting":[290],"need":[292],"unfettered":[294],"access":[295],"treatment.":[297]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-11-08T00:00:00"}